4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-22-005990
Director acquired 250,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Horne William B. · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-26 | Exercise or conversion : show line 1 in the form | +250,000 | $0.00 | $100 | 500,000 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-26 | Exercise or conversion : show line 2 in the form Stock Options (Right to Buy) | −250,000 | 2,000,000 | D |
Loading xslF345X03/marketforms-56047.xml…